← Leaderboards
John C Davis
University Of California San Francisco
$585,210
Attributed
$585,210
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$585,210 · 2
By mechanism
K23$438,756 · 1
N01$146,454 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Nancy L Lane$1,692
- Neal L Benowitz$31,329,042
- John Davis$35,811
- John E. Mendelson$11,971,442
- Lindsey Ann Criswell$20,453,502
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsRheumatoid ArthritisHuman Therapy EvaluationHuman SubjectClinical ResearchX Ray SpectrometryAndrogensBlood Sedimentation TestBody CompositionBone DensityHormone TherapyMaleMuscle StrengthOsteoporosisQuality Of LifeSkeletal Disorder ChemotherapyTestosteroneTransdermal Drug DeliveryAcute Phase ProteinAntiarthritic AgentChimeric ProteinsArthritis TherapyCytokine ReceptorsDrug Screening /Evaluation
Grant awards (4)
ANDROGEN AS ADJUNCT THERAPY IN RHEUMATOID ARTHRITIS$146,252
K23 · FY2002 · AR
ANDROGEN AS ADJUNCT THERAPY IN RHEUMATOID ARTHRITIS$146,252
K23 · FY2001 · AR
CLINICAL TRIAL OF ANTI-TUMOR NECROSIS FACTOR-ALPHA IN$146,454
N01 · FY2000 · AR
ANDROGEN AS ADJUNCT THERAPY IN RHEUMATOID ARTHRITIS$146,252
K23 · FY2000 · AR